Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jun 26, 2009
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $6.09
Jun 26, 2009
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $6.09
Jun 26, 2009
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 $6.09
Jun 26, 2009
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $6.09
Jun 26, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 $6.09
Jun 26, 2009
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $6.09
May 21, 2009
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $4.89
May 20, 2009
Director
Director Other acquisition or disposition -- --
May 20, 2009
Director
Director Open market or private purchase of non-derivative or derivative security 1,000 $5.15
May 06, 2009
Vice President Finance
Vice President Finance Open market or private purchase of non-derivative or derivative security 85,000 $2.70
May 06, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 290,000 $2.70
May 05, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,730 $2.60
May 05, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,434 $2.62
May 05, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 601 $2.65
May 05, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,435 $2.63
May 05, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 800 $2.64
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,900 $2.41
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 700 $2.40
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 900 $2.45
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 400 $2.39
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 50 $2.44
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,566 $2.43
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 600 $2.39
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 400 $2.40
Apr 29, 2009
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 400 $2.40

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.